nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3A—Alzheimer's disease	0.417	0.591	CbGaD
Lithium—GSK3B—Alzheimer's disease	0.289	0.409	CbGaD
Lithium—Fasciculation—Donepezil—Alzheimer's disease	0.00418	0.0395	CcSEcCtD
Lithium—IMPA1—forebrain—Alzheimer's disease	0.00416	0.0755	CbGeAlD
Lithium—IMPA1—telencephalon—Alzheimer's disease	0.00382	0.0694	CbGeAlD
Lithium—GRIA3—forebrain—Alzheimer's disease	0.00354	0.0642	CbGeAlD
Lithium—GSK3B—embryo—Alzheimer's disease	0.00346	0.0628	CbGeAlD
Lithium—GRIA3—telencephalon—Alzheimer's disease	0.00325	0.059	CbGeAlD
Lithium—Cogwheel rigidity—Rivastigmine—Alzheimer's disease	0.00314	0.0297	CcSEcCtD
Lithium—GSK3B—forebrain—Alzheimer's disease	0.00306	0.0556	CbGeAlD
Lithium—GSK3B—telencephalon—Alzheimer's disease	0.00281	0.0511	CbGeAlD
Lithium—GSK3A—forebrain—Alzheimer's disease	0.00266	0.0483	CbGeAlD
Lithium—GSK3A—telencephalon—Alzheimer's disease	0.00245	0.0444	CbGeAlD
Lithium—IMPA1—nervous system—Alzheimer's disease	0.00226	0.041	CbGeAlD
Lithium—IMPA1—central nervous system—Alzheimer's disease	0.00217	0.0394	CbGeAlD
Lithium—Polydipsia—Donepezil—Alzheimer's disease	0.00208	0.0197	CcSEcCtD
Lithium—Electrocardiogram change—Memantine—Alzheimer's disease	0.00205	0.0194	CcSEcCtD
Lithium—GRIA3—nervous system—Alzheimer's disease	0.00192	0.0348	CbGeAlD
Lithium—Polydipsia—Memantine—Alzheimer's disease	0.00189	0.0179	CcSEcCtD
Lithium—GRIA3—central nervous system—Alzheimer's disease	0.00185	0.0335	CbGeAlD
Lithium—Goitre—Donepezil—Alzheimer's disease	0.00181	0.0171	CcSEcCtD
Lithium—GRIA3—cerebellum—Alzheimer's disease	0.00181	0.0328	CbGeAlD
Lithium—Muscle contractions involuntary—Galantamine—Alzheimer's disease	0.00173	0.0163	CcSEcCtD
Lithium—IMPA1—brain—Alzheimer's disease	0.00173	0.0313	CbGeAlD
Lithium—GSK3B—nervous system—Alzheimer's disease	0.00166	0.0302	CbGeAlD
Lithium—Goitre—Rivastigmine—Alzheimer's disease	0.00161	0.0152	CcSEcCtD
Lithium—GSK3B—central nervous system—Alzheimer's disease	0.0016	0.029	CbGeAlD
Lithium—Dental caries—Memantine—Alzheimer's disease	0.00158	0.0149	CcSEcCtD
Lithium—GSK3B—cerebellum—Alzheimer's disease	0.00156	0.0284	CbGeAlD
Lithium—Dental caries—Rivastigmine—Alzheimer's disease	0.00154	0.0146	CcSEcCtD
Lithium—Hyperthyroidism—Memantine—Alzheimer's disease	0.00148	0.014	CcSEcCtD
Lithium—GRIA3—brain—Alzheimer's disease	0.00147	0.0266	CbGeAlD
Lithium—GSK3A—nervous system—Alzheimer's disease	0.00144	0.0262	CbGeAlD
Lithium—GSK3A—central nervous system—Alzheimer's disease	0.00139	0.0252	CbGeAlD
Lithium—GSK3A—cerebellum—Alzheimer's disease	0.00136	0.0247	CbGeAlD
Lithium—Muscle contractions involuntary—Donepezil—Alzheimer's disease	0.00134	0.0126	CcSEcCtD
Lithium—IMPA2—brain—Alzheimer's disease	0.00129	0.0235	CbGeAlD
Lithium—GSK3B—brain—Alzheimer's disease	0.00127	0.0231	CbGeAlD
Lithium—Muscle contractions involuntary—Memantine—Alzheimer's disease	0.00121	0.0115	CcSEcCtD
Lithium—Muscle contractions involuntary—Rivastigmine—Alzheimer's disease	0.00119	0.0112	CcSEcCtD
Lithium—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00111	0.0105	CcSEcCtD
Lithium—GSK3A—brain—Alzheimer's disease	0.0011	0.02	CbGeAlD
Lithium—Psoriasis—Donepezil—Alzheimer's disease	0.00103	0.00971	CcSEcCtD
Lithium—Hypothyroidism—Memantine—Alzheimer's disease	0.000914	0.00863	CcSEcCtD
Lithium—Nystagmus—Donepezil—Alzheimer's disease	0.000905	0.00854	CcSEcCtD
Lithium—Hypothyroidism—Rivastigmine—Alzheimer's disease	0.000894	0.00845	CcSEcCtD
Lithium—Albuminuria—Donepezil—Alzheimer's disease	0.000866	0.00818	CcSEcCtD
Lithium—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.000858	0.00811	CcSEcCtD
Lithium—Skin ulcer—Donepezil—Alzheimer's disease	0.00083	0.00784	CcSEcCtD
Lithium—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.00081	0.00765	CcSEcCtD
Lithium—Urinary incontinence—Galantamine—Alzheimer's disease	0.000805	0.0076	CcSEcCtD
Lithium—Nystagmus—Rivastigmine—Alzheimer's disease	0.000804	0.00759	CcSEcCtD
Lithium—Glycosuria—Donepezil—Alzheimer's disease	0.000798	0.00753	CcSEcCtD
Lithium—Stupor—Memantine—Alzheimer's disease	0.000786	0.00742	CcSEcCtD
Lithium—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.000779	0.00736	CcSEcCtD
Lithium—Albuminuria—Rivastigmine—Alzheimer's disease	0.000769	0.00726	CcSEcCtD
Lithium—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.000762	0.0072	CcSEcCtD
Lithium—Skin ulcer—Memantine—Alzheimer's disease	0.000754	0.00712	CcSEcCtD
Lithium—Skin ulcer—Rivastigmine—Alzheimer's disease	0.000737	0.00696	CcSEcCtD
Lithium—Hypertonia—Galantamine—Alzheimer's disease	0.000731	0.0069	CcSEcCtD
Lithium—Leukocytosis—Donepezil—Alzheimer's disease	0.000688	0.00649	CcSEcCtD
Lithium—Dysarthria—Donepezil—Alzheimer's disease	0.000683	0.00645	CcSEcCtD
Lithium—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.000628	0.00593	CcSEcCtD
Lithium—Leukocytosis—Memantine—Alzheimer's disease	0.000624	0.0059	CcSEcCtD
Lithium—Urinary incontinence—Donepezil—Alzheimer's disease	0.000624	0.00589	CcSEcCtD
Lithium—Oliguria—Rivastigmine—Alzheimer's disease	0.000623	0.00588	CcSEcCtD
Lithium—Lethargy—Galantamine—Alzheimer's disease	0.000618	0.00583	CcSEcCtD
Lithium—Leukocytosis—Rivastigmine—Alzheimer's disease	0.000611	0.00577	CcSEcCtD
Lithium—Dysarthria—Rivastigmine—Alzheimer's disease	0.000607	0.00573	CcSEcCtD
Lithium—Coordination abnormal—Memantine—Alzheimer's disease	0.000598	0.00564	CcSEcCtD
Lithium—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.000585	0.00552	CcSEcCtD
Lithium—Ataxia—Galantamine—Alzheimer's disease	0.000569	0.00538	CcSEcCtD
Lithium—Depressed level of consciousness—Memantine—Alzheimer's disease	0.000567	0.00535	CcSEcCtD
Lithium—Urinary incontinence—Memantine—Alzheimer's disease	0.000567	0.00535	CcSEcCtD
Lithium—Hypertonia—Donepezil—Alzheimer's disease	0.000567	0.00535	CcSEcCtD
Lithium—Dehydration—Galantamine—Alzheimer's disease	0.000563	0.00532	CcSEcCtD
Lithium—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000558	0.00527	CcSEcCtD
Lithium—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.000554	0.00524	CcSEcCtD
Lithium—Coma—Memantine—Alzheimer's disease	0.000536	0.00506	CcSEcCtD
Lithium—Gastritis—Galantamine—Alzheimer's disease	0.000536	0.00506	CcSEcCtD
Lithium—Muscular weakness—Galantamine—Alzheimer's disease	0.000534	0.00504	CcSEcCtD
Lithium—Urine output increased—Memantine—Alzheimer's disease	0.000531	0.00501	CcSEcCtD
Lithium—Coma—Rivastigmine—Alzheimer's disease	0.000525	0.00495	CcSEcCtD
Lithium—Urine output increased—Rivastigmine—Alzheimer's disease	0.000519	0.0049	CcSEcCtD
Lithium—Hypertonia—Memantine—Alzheimer's disease	0.000514	0.00486	CcSEcCtD
Lithium—Hypertonia—Rivastigmine—Alzheimer's disease	0.000503	0.00475	CcSEcCtD
Lithium—Thirst—Donepezil—Alzheimer's disease	0.000493	0.00466	CcSEcCtD
Lithium—Polyuria—Memantine—Alzheimer's disease	0.000485	0.00458	CcSEcCtD
Lithium—Polyuria—Rivastigmine—Alzheimer's disease	0.000475	0.00448	CcSEcCtD
Lithium—Weight decreased—Galantamine—Alzheimer's disease	0.000473	0.00447	CcSEcCtD
Lithium—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000472	0.00446	CcSEcCtD
Lithium—Ataxia—Donepezil—Alzheimer's disease	0.000441	0.00417	CcSEcCtD
Lithium—Thirst—Rivastigmine—Alzheimer's disease	0.000438	0.00414	CcSEcCtD
Lithium—Dehydration—Donepezil—Alzheimer's disease	0.000436	0.00412	CcSEcCtD
Lithium—Lethargy—Memantine—Alzheimer's disease	0.000435	0.00411	CcSEcCtD
Lithium—Dry skin—Donepezil—Alzheimer's disease	0.00043	0.00406	CcSEcCtD
Lithium—Bradycardia—Galantamine—Alzheimer's disease	0.000426	0.00403	CcSEcCtD
Lithium—Hallucination—Galantamine—Alzheimer's disease	0.000417	0.00394	CcSEcCtD
Lithium—Gastritis—Donepezil—Alzheimer's disease	0.000415	0.00392	CcSEcCtD
Lithium—Muscular weakness—Donepezil—Alzheimer's disease	0.000414	0.00391	CcSEcCtD
Lithium—Ataxia—Memantine—Alzheimer's disease	0.000401	0.00378	CcSEcCtD
Lithium—Dehydration—Memantine—Alzheimer's disease	0.000396	0.00374	CcSEcCtD
Lithium—Ataxia—Rivastigmine—Alzheimer's disease	0.000392	0.0037	CcSEcCtD
Lithium—Tinnitus—Galantamine—Alzheimer's disease	0.000391	0.00369	CcSEcCtD
Lithium—Dry skin—Memantine—Alzheimer's disease	0.00039	0.00369	CcSEcCtD
Lithium—Dehydration—Rivastigmine—Alzheimer's disease	0.000388	0.00366	CcSEcCtD
Lithium—Dry skin—Rivastigmine—Alzheimer's disease	0.000382	0.00361	CcSEcCtD
Lithium—Gastritis—Memantine—Alzheimer's disease	0.000377	0.00356	CcSEcCtD
Lithium—Muscular weakness—Memantine—Alzheimer's disease	0.000376	0.00355	CcSEcCtD
Lithium—Arrhythmia—Galantamine—Alzheimer's disease	0.000374	0.00353	CcSEcCtD
Lithium—Weight increased—Donepezil—Alzheimer's disease	0.000369	0.00348	CcSEcCtD
Lithium—Gastritis—Rivastigmine—Alzheimer's disease	0.000369	0.00348	CcSEcCtD
Lithium—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000368	0.00347	CcSEcCtD
Lithium—Weight decreased—Donepezil—Alzheimer's disease	0.000367	0.00346	CcSEcCtD
Lithium—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000366	0.00345	CcSEcCtD
Lithium—Flatulence—Galantamine—Alzheimer's disease	0.000359	0.00339	CcSEcCtD
Lithium—Dysgeusia—Galantamine—Alzheimer's disease	0.000357	0.00337	CcSEcCtD
Lithium—Vision blurred—Galantamine—Alzheimer's disease	0.000344	0.00324	CcSEcCtD
Lithium—Tremor—Galantamine—Alzheimer's disease	0.000342	0.00323	CcSEcCtD
Lithium—Erectile dysfunction—Memantine—Alzheimer's disease	0.000339	0.0032	CcSEcCtD
Lithium—Weight increased—Memantine—Alzheimer's disease	0.000335	0.00316	CcSEcCtD
Lithium—Agitation—Galantamine—Alzheimer's disease	0.000335	0.00316	CcSEcCtD
Lithium—Weight decreased—Memantine—Alzheimer's disease	0.000333	0.00315	CcSEcCtD
Lithium—Hyperglycaemia—Memantine—Alzheimer's disease	0.000332	0.00314	CcSEcCtD
Lithium—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000332	0.00313	CcSEcCtD
Lithium—Bradycardia—Donepezil—Alzheimer's disease	0.00033	0.00312	CcSEcCtD
Lithium—Weight increased—Rivastigmine—Alzheimer's disease	0.000328	0.0031	CcSEcCtD
Lithium—Vertigo—Galantamine—Alzheimer's disease	0.000328	0.00309	CcSEcCtD
Lithium—Syncope—Galantamine—Alzheimer's disease	0.000327	0.00309	CcSEcCtD
Lithium—Weight decreased—Rivastigmine—Alzheimer's disease	0.000326	0.00308	CcSEcCtD
Lithium—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000325	0.00307	CcSEcCtD
Lithium—Hallucination—Donepezil—Alzheimer's disease	0.000323	0.00305	CcSEcCtD
Lithium—Drowsiness—Rivastigmine—Alzheimer's disease	0.000321	0.00303	CcSEcCtD
Lithium—Loss of consciousness—Galantamine—Alzheimer's disease	0.00032	0.00303	CcSEcCtD
Lithium—Convulsion—Galantamine—Alzheimer's disease	0.000316	0.00298	CcSEcCtD
Lithium—Arthralgia—Galantamine—Alzheimer's disease	0.00031	0.00293	CcSEcCtD
Lithium—Discomfort—Galantamine—Alzheimer's disease	0.000307	0.0029	CcSEcCtD
Lithium—Dry mouth—Galantamine—Alzheimer's disease	0.000304	0.00287	CcSEcCtD
Lithium—Tinnitus—Donepezil—Alzheimer's disease	0.000303	0.00286	CcSEcCtD
Lithium—Confusional state—Galantamine—Alzheimer's disease	0.0003	0.00283	CcSEcCtD
Lithium—Bradycardia—Memantine—Alzheimer's disease	0.0003	0.00283	CcSEcCtD
Lithium—Bradycardia—Rivastigmine—Alzheimer's disease	0.000294	0.00277	CcSEcCtD
Lithium—Hallucination—Memantine—Alzheimer's disease	0.000293	0.00277	CcSEcCtD
Lithium—Shock—Galantamine—Alzheimer's disease	0.000293	0.00276	CcSEcCtD
Lithium—Arrhythmia—Donepezil—Alzheimer's disease	0.00029	0.00274	CcSEcCtD
Lithium—Hallucination—Rivastigmine—Alzheimer's disease	0.000287	0.00271	CcSEcCtD
Lithium—Alopecia—Donepezil—Alzheimer's disease	0.000287	0.00271	CcSEcCtD
Lithium—Anorexia—Galantamine—Alzheimer's disease	0.000284	0.00268	CcSEcCtD
Lithium—Flatulence—Donepezil—Alzheimer's disease	0.000278	0.00263	CcSEcCtD
Lithium—Hypotension—Galantamine—Alzheimer's disease	0.000278	0.00263	CcSEcCtD
Lithium—Dysgeusia—Donepezil—Alzheimer's disease	0.000277	0.00261	CcSEcCtD
Lithium—Tinnitus—Memantine—Alzheimer's disease	0.000275	0.00259	CcSEcCtD
Lithium—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000271	0.00256	CcSEcCtD
Lithium—Tinnitus—Rivastigmine—Alzheimer's disease	0.000269	0.00254	CcSEcCtD
Lithium—Vision blurred—Donepezil—Alzheimer's disease	0.000266	0.00251	CcSEcCtD
Lithium—Tremor—Donepezil—Alzheimer's disease	0.000265	0.0025	CcSEcCtD
Lithium—Somnolence—Galantamine—Alzheimer's disease	0.000265	0.0025	CcSEcCtD
Lithium—Arrhythmia—Memantine—Alzheimer's disease	0.000263	0.00249	CcSEcCtD
Lithium—Dyspepsia—Galantamine—Alzheimer's disease	0.000262	0.00247	CcSEcCtD
Lithium—Alopecia—Memantine—Alzheimer's disease	0.00026	0.00246	CcSEcCtD
Lithium—Agitation—Donepezil—Alzheimer's disease	0.00026	0.00245	CcSEcCtD
Lithium—Decreased appetite—Galantamine—Alzheimer's disease	0.000259	0.00244	CcSEcCtD
Lithium—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000258	0.00243	CcSEcCtD
Lithium—Fatigue—Galantamine—Alzheimer's disease	0.000257	0.00242	CcSEcCtD
Lithium—Alopecia—Rivastigmine—Alzheimer's disease	0.000255	0.00241	CcSEcCtD
Lithium—Vertigo—Donepezil—Alzheimer's disease	0.000254	0.0024	CcSEcCtD
Lithium—Syncope—Donepezil—Alzheimer's disease	0.000253	0.00239	CcSEcCtD
Lithium—Flatulence—Memantine—Alzheimer's disease	0.000253	0.00239	CcSEcCtD
Lithium—Dysgeusia—Memantine—Alzheimer's disease	0.000251	0.00237	CcSEcCtD
Lithium—Loss of consciousness—Donepezil—Alzheimer's disease	0.000248	0.00235	CcSEcCtD
Lithium—Flatulence—Rivastigmine—Alzheimer's disease	0.000247	0.00234	CcSEcCtD
Lithium—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000246	0.00232	CcSEcCtD
Lithium—Feeling abnormal—Galantamine—Alzheimer's disease	0.000245	0.00232	CcSEcCtD
Lithium—Convulsion—Donepezil—Alzheimer's disease	0.000245	0.00231	CcSEcCtD
Lithium—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000243	0.0023	CcSEcCtD
Lithium—Vision blurred—Memantine—Alzheimer's disease	0.000242	0.00228	CcSEcCtD
Lithium—Arthralgia—Donepezil—Alzheimer's disease	0.000241	0.00227	CcSEcCtD
Lithium—Tremor—Memantine—Alzheimer's disease	0.00024	0.00227	CcSEcCtD
Lithium—Discomfort—Donepezil—Alzheimer's disease	0.000238	0.00224	CcSEcCtD
Lithium—Vision blurred—Rivastigmine—Alzheimer's disease	0.000237	0.00223	CcSEcCtD
Lithium—Agitation—Memantine—Alzheimer's disease	0.000236	0.00223	CcSEcCtD
Lithium—Dry mouth—Donepezil—Alzheimer's disease	0.000235	0.00222	CcSEcCtD
Lithium—Body temperature increased—Galantamine—Alzheimer's disease	0.000235	0.00222	CcSEcCtD
Lithium—Abdominal pain—Galantamine—Alzheimer's disease	0.000235	0.00222	CcSEcCtD
Lithium—Tremor—Rivastigmine—Alzheimer's disease	0.000235	0.00222	CcSEcCtD
Lithium—Confusional state—Donepezil—Alzheimer's disease	0.000233	0.0022	CcSEcCtD
Lithium—Agitation—Rivastigmine—Alzheimer's disease	0.000231	0.00218	CcSEcCtD
Lithium—Oedema—Donepezil—Alzheimer's disease	0.000231	0.00218	CcSEcCtD
Lithium—Vertigo—Memantine—Alzheimer's disease	0.00023	0.00218	CcSEcCtD
Lithium—Syncope—Memantine—Alzheimer's disease	0.00023	0.00217	CcSEcCtD
Lithium—Shock—Donepezil—Alzheimer's disease	0.000227	0.00214	CcSEcCtD
Lithium—Vertigo—Rivastigmine—Alzheimer's disease	0.000225	0.00213	CcSEcCtD
Lithium—Loss of consciousness—Memantine—Alzheimer's disease	0.000225	0.00213	CcSEcCtD
Lithium—Syncope—Rivastigmine—Alzheimer's disease	0.000225	0.00213	CcSEcCtD
Lithium—Convulsion—Memantine—Alzheimer's disease	0.000222	0.0021	CcSEcCtD
Lithium—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000221	0.00208	CcSEcCtD
Lithium—Anorexia—Donepezil—Alzheimer's disease	0.00022	0.00208	CcSEcCtD
Lithium—Arthralgia—Memantine—Alzheimer's disease	0.000218	0.00206	CcSEcCtD
Lithium—Convulsion—Rivastigmine—Alzheimer's disease	0.000217	0.00205	CcSEcCtD
Lithium—Discomfort—Memantine—Alzheimer's disease	0.000216	0.00204	CcSEcCtD
Lithium—Hypotension—Donepezil—Alzheimer's disease	0.000215	0.00203	CcSEcCtD
Lithium—Arthralgia—Rivastigmine—Alzheimer's disease	0.000214	0.00202	CcSEcCtD
Lithium—Dry mouth—Memantine—Alzheimer's disease	0.000214	0.00202	CcSEcCtD
Lithium—Asthenia—Galantamine—Alzheimer's disease	0.000213	0.00202	CcSEcCtD
Lithium—Confusional state—Memantine—Alzheimer's disease	0.000211	0.00199	CcSEcCtD
Lithium—Discomfort—Rivastigmine—Alzheimer's disease	0.000211	0.00199	CcSEcCtD
Lithium—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00021	0.00198	CcSEcCtD
Lithium—Oedema—Memantine—Alzheimer's disease	0.000209	0.00198	CcSEcCtD
Lithium—Dry mouth—Rivastigmine—Alzheimer's disease	0.000209	0.00197	CcSEcCtD
Lithium—Confusional state—Rivastigmine—Alzheimer's disease	0.000207	0.00195	CcSEcCtD
Lithium—Shock—Memantine—Alzheimer's disease	0.000206	0.00195	CcSEcCtD
Lithium—Somnolence—Donepezil—Alzheimer's disease	0.000205	0.00194	CcSEcCtD
Lithium—Oedema—Rivastigmine—Alzheimer's disease	0.000205	0.00193	CcSEcCtD
Lithium—Diarrhoea—Galantamine—Alzheimer's disease	0.000204	0.00192	CcSEcCtD
Lithium—Dyspepsia—Donepezil—Alzheimer's disease	0.000203	0.00192	CcSEcCtD
Lithium—Shock—Rivastigmine—Alzheimer's disease	0.000202	0.0019	CcSEcCtD
Lithium—Decreased appetite—Donepezil—Alzheimer's disease	0.0002	0.00189	CcSEcCtD
Lithium—Anorexia—Memantine—Alzheimer's disease	0.0002	0.00188	CcSEcCtD
Lithium—Fatigue—Donepezil—Alzheimer's disease	0.000199	0.00188	CcSEcCtD
Lithium—Dizziness—Galantamine—Alzheimer's disease	0.000197	0.00186	CcSEcCtD
Lithium—Hypotension—Memantine—Alzheimer's disease	0.000196	0.00185	CcSEcCtD
Lithium—Anorexia—Rivastigmine—Alzheimer's disease	0.000195	0.00184	CcSEcCtD
Lithium—Hypotension—Rivastigmine—Alzheimer's disease	0.000191	0.00181	CcSEcCtD
Lithium—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000191	0.0018	CcSEcCtD
Lithium—Feeling abnormal—Donepezil—Alzheimer's disease	0.00019	0.00179	CcSEcCtD
Lithium—Vomiting—Galantamine—Alzheimer's disease	0.000189	0.00179	CcSEcCtD
Lithium—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000189	0.00178	CcSEcCtD
Lithium—Rash—Galantamine—Alzheimer's disease	0.000188	0.00177	CcSEcCtD
Lithium—Dermatitis—Galantamine—Alzheimer's disease	0.000187	0.00177	CcSEcCtD
Lithium—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000187	0.00176	CcSEcCtD
Lithium—Headache—Galantamine—Alzheimer's disease	0.000186	0.00176	CcSEcCtD
Lithium—Somnolence—Memantine—Alzheimer's disease	0.000186	0.00176	CcSEcCtD
Lithium—Dyspepsia—Memantine—Alzheimer's disease	0.000184	0.00174	CcSEcCtD
Lithium—Abdominal pain—Donepezil—Alzheimer's disease	0.000182	0.00172	CcSEcCtD
Lithium—Body temperature increased—Donepezil—Alzheimer's disease	0.000182	0.00172	CcSEcCtD
Lithium—Somnolence—Rivastigmine—Alzheimer's disease	0.000182	0.00172	CcSEcCtD
Lithium—Decreased appetite—Memantine—Alzheimer's disease	0.000182	0.00172	CcSEcCtD
Lithium—Fatigue—Memantine—Alzheimer's disease	0.000181	0.0017	CcSEcCtD
Lithium—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00018	0.0017	CcSEcCtD
Lithium—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000178	0.00168	CcSEcCtD
Lithium—Nausea—Galantamine—Alzheimer's disease	0.000177	0.00167	CcSEcCtD
Lithium—Fatigue—Rivastigmine—Alzheimer's disease	0.000177	0.00167	CcSEcCtD
Lithium—Feeling abnormal—Memantine—Alzheimer's disease	0.000173	0.00163	CcSEcCtD
Lithium—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000171	0.00162	CcSEcCtD
Lithium—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000169	0.00159	CcSEcCtD
Lithium—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000167	0.00158	CcSEcCtD
Lithium—Abdominal pain—Memantine—Alzheimer's disease	0.000166	0.00156	CcSEcCtD
Lithium—Body temperature increased—Memantine—Alzheimer's disease	0.000166	0.00156	CcSEcCtD
Lithium—Asthenia—Donepezil—Alzheimer's disease	0.000165	0.00156	CcSEcCtD
Lithium—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000162	0.00153	CcSEcCtD
Lithium—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000162	0.00153	CcSEcCtD
Lithium—Diarrhoea—Donepezil—Alzheimer's disease	0.000158	0.00149	CcSEcCtD
Lithium—Dizziness—Donepezil—Alzheimer's disease	0.000152	0.00144	CcSEcCtD
Lithium—Asthenia—Memantine—Alzheimer's disease	0.00015	0.00142	CcSEcCtD
Lithium—Asthenia—Rivastigmine—Alzheimer's disease	0.000147	0.00139	CcSEcCtD
Lithium—Vomiting—Donepezil—Alzheimer's disease	0.000147	0.00138	CcSEcCtD
Lithium—Rash—Donepezil—Alzheimer's disease	0.000145	0.00137	CcSEcCtD
Lithium—Dermatitis—Donepezil—Alzheimer's disease	0.000145	0.00137	CcSEcCtD
Lithium—Headache—Donepezil—Alzheimer's disease	0.000144	0.00136	CcSEcCtD
Lithium—Diarrhoea—Memantine—Alzheimer's disease	0.000143	0.00135	CcSEcCtD
Lithium—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00014	0.00132	CcSEcCtD
Lithium—Dizziness—Memantine—Alzheimer's disease	0.000138	0.00131	CcSEcCtD
Lithium—Nausea—Donepezil—Alzheimer's disease	0.000137	0.00129	CcSEcCtD
Lithium—Dizziness—Rivastigmine—Alzheimer's disease	0.000135	0.00128	CcSEcCtD
Lithium—Vomiting—Memantine—Alzheimer's disease	0.000133	0.00126	CcSEcCtD
Lithium—Rash—Memantine—Alzheimer's disease	0.000132	0.00125	CcSEcCtD
Lithium—Dermatitis—Memantine—Alzheimer's disease	0.000132	0.00125	CcSEcCtD
Lithium—Headache—Memantine—Alzheimer's disease	0.000131	0.00124	CcSEcCtD
Lithium—Vomiting—Rivastigmine—Alzheimer's disease	0.00013	0.00123	CcSEcCtD
Lithium—Rash—Rivastigmine—Alzheimer's disease	0.000129	0.00122	CcSEcCtD
Lithium—Dermatitis—Rivastigmine—Alzheimer's disease	0.000129	0.00122	CcSEcCtD
Lithium—Headache—Rivastigmine—Alzheimer's disease	0.000128	0.00121	CcSEcCtD
Lithium—Nausea—Memantine—Alzheimer's disease	0.000124	0.00117	CcSEcCtD
Lithium—Nausea—Rivastigmine—Alzheimer's disease	0.000122	0.00115	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—CREB1—Alzheimer's disease	2.13e-05	0.00016	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CASP3—Alzheimer's disease	2.13e-05	0.00016	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—F2—Alzheimer's disease	2.13e-05	0.00016	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—AKT1—Alzheimer's disease	2.12e-05	0.00016	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTGS2—Alzheimer's disease	2.12e-05	0.000159	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—Alzheimer's disease	2.11e-05	0.000159	CbGpPWpGaD
Lithium—GSK3B—Immune System—INPP5D—Alzheimer's disease	2.1e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—MAPK8—Alzheimer's disease	2.09e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—Alzheimer's disease	2.07e-05	0.000156	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PSEN2—Alzheimer's disease	2.07e-05	0.000156	CbGpPWpGaD
Lithium—GSK3A—Immune System—S100B—Alzheimer's disease	2.04e-05	0.000153	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—AKT1—Alzheimer's disease	2.03e-05	0.000153	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	2.03e-05	0.000153	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTSB—Alzheimer's disease	2.02e-05	0.000152	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTSD—Alzheimer's disease	2.01e-05	0.000151	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—AKT1—Alzheimer's disease	2e-05	0.00015	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NOTCH1—Alzheimer's disease	2e-05	0.00015	CbGpPWpGaD
Lithium—GSK3B—Disease—IAPP—Alzheimer's disease	2e-05	0.00015	CbGpPWpGaD
Lithium—GSK3A—Disease—ADAM10—Alzheimer's disease	1.99e-05	0.00015	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—Alzheimer's disease	1.98e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Immune System—PPP3CA—Alzheimer's disease	1.98e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—Alzheimer's disease	1.97e-05	0.000148	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—Alzheimer's disease	1.96e-05	0.000148	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MAPK8—Alzheimer's disease	1.96e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSENEN—Alzheimer's disease	1.96e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTK2B—Alzheimer's disease	1.95e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—Alzheimer's disease	1.95e-05	0.000147	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—AKT1—Alzheimer's disease	1.94e-05	0.000146	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APH1A—Alzheimer's disease	1.93e-05	0.000145	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—Alzheimer's disease	1.93e-05	0.000145	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—VEGFA—Alzheimer's disease	1.93e-05	0.000145	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CALM1—Alzheimer's disease	1.92e-05	0.000144	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—AKT1—Alzheimer's disease	1.91e-05	0.000144	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NPY—Alzheimer's disease	1.9e-05	0.000143	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CCL2—Alzheimer's disease	1.9e-05	0.000143	CbGpPWpGaD
Lithium—GSK3B—Immune System—GAB2—Alzheimer's disease	1.9e-05	0.000143	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IAPP—Alzheimer's disease	1.89e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—PPARG—Alzheimer's disease	1.88e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Immune System—GSK3A—Alzheimer's disease	1.88e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NCSTN—Alzheimer's disease	1.88e-05	0.000141	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—Alzheimer's disease	1.87e-05	0.00014	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—BCL2—Alzheimer's disease	1.87e-05	0.00014	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CREB1—Alzheimer's disease	1.86e-05	0.00014	CbGpPWpGaD
Lithium—GSK3B—Immune System—APP—Alzheimer's disease	1.85e-05	0.000139	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—Alzheimer's disease	1.85e-05	0.000139	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CALM1—Alzheimer's disease	1.84e-05	0.000139	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1A—Alzheimer's disease	1.84e-05	0.000139	CbGpPWpGaD
Lithium—GSK3B—Disease—ENO1—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CRH—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—AKT1—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—Alzheimer's disease	1.84e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LRP1—Alzheimer's disease	1.83e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Disease—PPP3CA—Alzheimer's disease	1.83e-05	0.000138	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—AKT1—Alzheimer's disease	1.83e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—Alzheimer's disease	1.82e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—AKT1—Alzheimer's disease	1.82e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—Alzheimer's disease	1.81e-05	0.000136	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—AKT1—Alzheimer's disease	1.81e-05	0.000136	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—Alzheimer's disease	1.8e-05	0.000136	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—AKT1—Alzheimer's disease	1.8e-05	0.000135	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—Alzheimer's disease	1.8e-05	0.000135	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GFAP—Alzheimer's disease	1.79e-05	0.000135	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GAL—Alzheimer's disease	1.79e-05	0.000135	CbGpPWpGaD
Lithium—GSK3A—Immune System—MEF2C—Alzheimer's disease	1.78e-05	0.000134	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—AKT1—Alzheimer's disease	1.77e-05	0.000133	CbGpPWpGaD
Lithium—GSK3A—Immune System—AGER—Alzheimer's disease	1.77e-05	0.000133	CbGpPWpGaD
Lithium—GSK3B—Disease—GAB2—Alzheimer's disease	1.75e-05	0.000132	CbGpPWpGaD
Lithium—GSK3A—Immune System—PRKCG—Alzheimer's disease	1.75e-05	0.000131	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NPS—Alzheimer's disease	1.74e-05	0.000131	CbGpPWpGaD
Lithium—GSK3B—Disease—GSK3A—Alzheimer's disease	1.74e-05	0.000131	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.73e-05	0.00013	CbGpPWpGaD
Lithium—GSK3B—Disease—APP—Alzheimer's disease	1.71e-05	0.000128	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTK2B—Alzheimer's disease	1.71e-05	0.000128	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—AKT1—Alzheimer's disease	1.69e-05	0.000127	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—AKT1—Alzheimer's disease	1.69e-05	0.000127	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—AKT1—Alzheimer's disease	1.69e-05	0.000127	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—Alzheimer's disease	1.69e-05	0.000127	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—AKT1—Alzheimer's disease	1.68e-05	0.000126	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—AKT1—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GAB2—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SST—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NTRK2—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3A—Disease—LPL—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—AKT1—Alzheimer's disease	1.66e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CREB1—Alzheimer's disease	1.64e-05	0.000123	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VEGFA—Alzheimer's disease	1.64e-05	0.000123	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	1.63e-05	0.000122	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APP—Alzheimer's disease	1.62e-05	0.000122	CbGpPWpGaD
Lithium—GSK3A—Disease—PRKCG—Alzheimer's disease	1.61e-05	0.000121	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—AKT1—Alzheimer's disease	1.6e-05	0.00012	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—A2M—Alzheimer's disease	1.58e-05	0.000119	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CREB1—Alzheimer's disease	1.58e-05	0.000119	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—AKT1—Alzheimer's disease	1.57e-05	0.000118	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—AKT1—Alzheimer's disease	1.56e-05	0.000117	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PSEN2—Alzheimer's disease	1.53e-05	0.000115	CbGpPWpGaD
Lithium—GSK3A—Disease—CCR5—Alzheimer's disease	1.53e-05	0.000115	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PLCB1—Alzheimer's disease	1.53e-05	0.000115	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK8—Alzheimer's disease	1.51e-05	0.000114	CbGpPWpGaD
Lithium—GSK3A—Immune System—CALM1—Alzheimer's disease	1.51e-05	0.000114	CbGpPWpGaD
Lithium—GSK3B—Immune System—S100B—Alzheimer's disease	1.5e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	1.5e-05	0.000113	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—Alzheimer's disease	1.49e-05	0.000112	CbGpPWpGaD
Lithium—GSK3B—Disease—ADAM10—Alzheimer's disease	1.47e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—Alzheimer's disease	1.46e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—AKT1—Alzheimer's disease	1.43e-05	0.000108	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NGFR—Alzheimer's disease	1.43e-05	0.000107	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPY—Alzheimer's disease	1.41e-05	0.000106	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IAPP—Alzheimer's disease	1.4e-05	0.000105	CbGpPWpGaD
Lithium—GSK3A—Disease—CALM1—Alzheimer's disease	1.4e-05	0.000105	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADAM10—Alzheimer's disease	1.39e-05	0.000105	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—Alzheimer's disease	1.39e-05	0.000105	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—Alzheimer's disease	1.39e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2—Alzheimer's disease	1.38e-05	0.000104	CbGpPWpGaD
Lithium—GSK3A—Disease—CAV1—Alzheimer's disease	1.38e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1A—Alzheimer's disease	1.36e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CRH—Alzheimer's disease	1.36e-05	0.000102	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—Alzheimer's disease	1.33e-05	0.0001	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—S100B—Alzheimer's disease	1.32e-05	9.9e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MEF2C—Alzheimer's disease	1.32e-05	9.9e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AGER—Alzheimer's disease	1.3e-05	9.81e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—GSK3B—Alzheimer's disease	1.3e-05	9.81e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS2—Alzheimer's disease	1.3e-05	9.75e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CREB1—Alzheimer's disease	1.29e-05	9.73e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCG—Alzheimer's disease	1.29e-05	9.71e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—Alzheimer's disease	1.29e-05	9.7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPS—Alzheimer's disease	1.29e-05	9.68e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOTCH1—Alzheimer's disease	1.28e-05	9.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PPP3CA—Alzheimer's disease	1.28e-05	9.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTK2B—Alzheimer's disease	1.26e-05	9.49e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF2—Alzheimer's disease	1.25e-05	9.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—Alzheimer's disease	1.25e-05	9.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SST—Alzheimer's disease	1.23e-05	9.23e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GAB2—Alzheimer's disease	1.23e-05	9.23e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NTRK2—Alzheimer's disease	1.23e-05	9.23e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—LPL—Alzheimer's disease	1.23e-05	9.22e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GSK3A—Alzheimer's disease	1.22e-05	9.15e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1R—Alzheimer's disease	1.21e-05	9.12e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—GSK3B—Alzheimer's disease	1.2e-05	9.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APP—Alzheimer's disease	1.2e-05	9e-05	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—Alzheimer's disease	1.2e-05	8.99e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CREB1—Alzheimer's disease	1.19e-05	8.99e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PRKCG—Alzheimer's disease	1.19e-05	8.97e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—Alzheimer's disease	1.19e-05	8.94e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—Alzheimer's disease	1.17e-05	8.79e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LPL—Alzheimer's disease	1.16e-05	8.74e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—Alzheimer's disease	1.15e-05	8.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MEF2C—Alzheimer's disease	1.15e-05	8.66e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—Alzheimer's disease	1.13e-05	8.51e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCG—Alzheimer's disease	1.13e-05	8.5e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—Alzheimer's disease	1.13e-05	8.5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLCB1—Alzheimer's disease	1.13e-05	8.49e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK8—Alzheimer's disease	1.12e-05	8.4e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CALM1—Alzheimer's disease	1.12e-05	8.4e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—Alzheimer's disease	1.1e-05	8.3e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NGF—Alzheimer's disease	1.1e-05	8.28e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—Alzheimer's disease	1.09e-05	8.17e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—Alzheimer's disease	1.07e-05	8.06e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—Alzheimer's disease	1.07e-05	8.05e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—Alzheimer's disease	1.07e-05	8.01e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—Alzheimer's disease	1.06e-05	7.99e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGFR—Alzheimer's disease	1.05e-05	7.92e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—Alzheimer's disease	1.05e-05	7.88e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—Alzheimer's disease	1.04e-05	7.84e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CALM1—Alzheimer's disease	1.03e-05	7.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADAM10—Alzheimer's disease	1.03e-05	7.74e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—Alzheimer's disease	1.03e-05	7.73e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CAV1—Alzheimer's disease	1.02e-05	7.66e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—Alzheimer's disease	1e-05	7.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CALM1—Alzheimer's disease	9.77e-06	7.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—Alzheimer's disease	9.74e-06	7.33e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—Alzheimer's disease	9.74e-06	7.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—S100B—Alzheimer's disease	9.73e-06	7.32e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—Alzheimer's disease	9.65e-06	7.26e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CAV1—Alzheimer's disease	9.65e-06	7.26e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—Alzheimer's disease	9.6e-06	7.22e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—Alzheimer's disease	9.58e-06	7.2e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CREB1—Alzheimer's disease	9.56e-06	7.19e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—Alzheimer's disease	9.53e-06	7.17e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOTCH1—Alzheimer's disease	9.48e-06	7.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—Alzheimer's disease	9.3e-06	6.99e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF2—Alzheimer's disease	9.26e-06	6.97e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—F2—Alzheimer's disease	9.18e-06	6.91e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOTCH1—Alzheimer's disease	8.99e-06	6.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1R—Alzheimer's disease	8.95e-06	6.74e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—Alzheimer's disease	8.91e-06	6.7e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CREB1—Alzheimer's disease	8.83e-06	6.64e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK8—Alzheimer's disease	8.8e-06	6.62e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—Alzheimer's disease	8.78e-06	6.6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LPL—Alzheimer's disease	8.58e-06	6.46e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—Alzheimer's disease	8.55e-06	6.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MEF2C—Alzheimer's disease	8.51e-06	6.4e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GSK3B—Alzheimer's disease	8.43e-06	6.34e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CREB1—Alzheimer's disease	8.37e-06	6.29e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCG—Alzheimer's disease	8.35e-06	6.28e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—Alzheimer's disease	8.32e-06	6.26e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—Alzheimer's disease	8.19e-06	6.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NGF—Alzheimer's disease	8.13e-06	6.12e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—Alzheimer's disease	8.08e-06	6.08e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—Alzheimer's disease	8.05e-06	6.05e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—Alzheimer's disease	8.03e-06	6.04e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—Alzheimer's disease	7.91e-06	5.95e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—Alzheimer's disease	7.74e-06	5.82e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—Alzheimer's disease	7.7e-06	5.79e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—Alzheimer's disease	7.45e-06	5.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—Alzheimer's disease	7.3e-06	5.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALM1—Alzheimer's disease	7.22e-06	5.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—Alzheimer's disease	7.2e-06	5.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—Alzheimer's disease	7.2e-06	5.41e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—Alzheimer's disease	7.13e-06	5.37e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CAV1—Alzheimer's disease	7.13e-06	5.36e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—Alzheimer's disease	7.1e-06	5.34e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—Alzheimer's disease	7.04e-06	5.3e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—Alzheimer's disease	6.89e-06	5.18e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—Alzheimer's disease	6.87e-06	5.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2—Alzheimer's disease	6.79e-06	5.1e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH1—Alzheimer's disease	6.64e-06	5e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—Alzheimer's disease	6.58e-06	4.95e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK8—Alzheimer's disease	6.51e-06	4.89e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—Alzheimer's disease	6.32e-06	4.75e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CASP3—Alzheimer's disease	6.19e-06	4.66e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CREB1—Alzheimer's disease	6.18e-06	4.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—Alzheimer's disease	6.15e-06	4.62e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—Alzheimer's disease	6.05e-06	4.55e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—Alzheimer's disease	5.95e-06	4.47e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK8—Alzheimer's disease	5.69e-06	4.28e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—Alzheimer's disease	5.62e-06	4.23e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—Alzheimer's disease	5.39e-06	4.06e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—Alzheimer's disease	5.26e-06	3.95e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—Alzheimer's disease	5.19e-06	3.91e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—Alzheimer's disease	5.19e-06	3.9e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—Alzheimer's disease	5.09e-06	3.83e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—Alzheimer's disease	4.82e-06	3.63e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—Alzheimer's disease	4.79e-06	3.6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CASP3—Alzheimer's disease	4.58e-06	3.44e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK8—Alzheimer's disease	4.21e-06	3.16e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—Alzheimer's disease	4.15e-06	3.13e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—Alzheimer's disease	3.97e-06	2.99e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—Alzheimer's disease	3.88e-06	2.92e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—Alzheimer's disease	3.84e-06	2.89e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—Alzheimer's disease	3.83e-06	2.88e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—Alzheimer's disease	3.64e-06	2.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—Alzheimer's disease	3.56e-06	2.68e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—Alzheimer's disease	3.54e-06	2.66e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—Alzheimer's disease	3.35e-06	2.52e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—Alzheimer's disease	2.93e-06	2.21e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—Alzheimer's disease	2.69e-06	2.02e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—Alzheimer's disease	2.48e-06	1.86e-05	CbGpPWpGaD
